Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
1983-10-28
|
| pubmed:language |
fre
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0040-5957
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
38
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
237-45
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:6612660-Adult,
pubmed-meshheading:6612660-Aged,
pubmed-meshheading:6612660-Anti-Arrhythmia Agents,
pubmed-meshheading:6612660-Humans,
pubmed-meshheading:6612660-Imidazoles,
pubmed-meshheading:6612660-Kinetics,
pubmed-meshheading:6612660-Male,
pubmed-meshheading:6612660-Middle Aged,
pubmed-meshheading:6612660-Myocardial Infarction
|
| pubmed:articleTitle |
[Pharmacokinetic study of a new antiarrhythmic drug, cibenzoline, during the acute phase of myocardial infarction. Therapeutic correlations].
|
| pubmed:publicationType |
Journal Article,
English Abstract
|